Genpact Limited
G · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.89 | 0.13 | -9.51 | 1.25 |
| FCF Yield | 6.92% | 6.83% | 4.56% | 6.39% |
| EV / EBITDA | 9.92 | 9.38 | 14.68 | 15.61 |
| Quality | ||||
| ROIC | 12.96% | 16.57% | 10.22% | 9.42% |
| Gross Margin | 35.45% | 35.08% | 35.15% | 35.60% |
| Cash Conversion Ratio | 1.20 | 0.78 | 1.26 | 1.88 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.93% | 3.63% | 5.62% | 4.54% |
| Free Cash Flow Growth | 22.72% | 10.98% | -38.89% | 24.05% |
| Safety | ||||
| Net Debt / EBITDA | 0.93 | 1.19 | 1.61 | 1.55 |
| Interest Coverage | 8.83 | 9.51 | 8.64 | 8.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 89.94 | 88.95 | 79.42 | 77.81 |